A product of Sunlight Foundation

Ferguson Strategies

Campaign Finance

$120,296 Given
Information

Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:

  • contributions under $200 are not reported, and so are not included in totals.
  • only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
  • contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
  • corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
  • organization totals include known subsidiaries of the organization.

For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.

  • Top Recipients

    PAC Color Block
    Organization's PAC(s)
    Employee Color Block
    Associated Individuals
    Includes contributions from the organization’s employees, their family members, and its political action committee.
  • Republicans vs. Democrats

    in dollars
  • State vs. Federal

    in dollars
  • Top PAC Recipients

    PAC Color Block
    Organization's PAC(s)
    Employee Color Block
    Associated Individuals
    Includes contributions from the organization’s employees, their family members, and its political action committee.
View all campaign finance data for Ferguson Strategies Sources: OpenSecrets.org

Lobbying

$900,000 Income
Information

Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.

For more information, please see our lobbying methodology page.

covers roughly through Q3, 2013

Lobbying Carried Out by Ferguson Strategies

  • Names of Lobbyists
  • Client Amount
    CR Bard Inc $240,000
    Public Service Enterprise Group $160,000
    Medicines Co $140,000
    Eli Lilly & Co $120,000
    Novartis Corp $100,000
    Celgene Corp $60,000
    Merck & Co $40,000
    Bode Technology Group $40,000
  • Most Frequently Disclosed Lobbying Issues
    • Health Issues,
    • Taxes,
    • Energy & Nuclear Power,
    • Finance,
    • Manufacturing,
    • Medicare & Medicaid,
    • Copyright, Patent & Trademark,
    • Fed Budget & Appropriations,
    • Defense,
    • Transportation
  • Most Frequently Disclosed Bills
    Bill No. Title
    H.R.436 Protect Medical Innovation Act of 2011
    S.17 Medical Device Access and Innovation Protection Act
    H.R.910 Energy Tax Prevention Act of 2011
    H.R.2746 Cancer Drug Coverage Parity Act of 2011
    H.R.452 Medicare Decisions Accountability Act of 2011
    S.510 Research of Alcohol Detection Systems for Stopping Alcohol-related Fatalities Everywhere Act of 2011
    H.R.1249 America Invents Act
    H.R.3527 Protecting Main Street End-Users From Excessive Regulation
    H.R.3208 Patients Come First Act of 2011
    H.R.3209 Premarket Predictability Act of 2011
  • Recent Lobbying Contracts
    Date Client Summary
    Feb. 14, 2014 Endo Pharmaceuticals Policy and implementation issues relating to Public Law No. 111-148, the "Patient Protection and Affordable Care Act." Issues relating to Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Prescription Drug User Fee program and the Medical Device User Free program. Policy issues relating to prescription drug labeling. View registration
    Feb. 3, 2014 NASDAQ OMX Group Financial services, including transparency and conflicts of interest in the proxy advisory industry, and SEC conflicts minerals regulation; immigration issues, including H-1B visas; cybersecurity; and tax reform. View registration
    Feb. 3, 2014 Dendreon Corp Policy and implementation issues relating to Public Law No. 111-148, the "Patient Protection and Affordable Care Act." Issues relating to Public Law No. 112-144, the "Food and Drug Administration Safety and Innovation Act," specifically those sections relating to the implementation of the Prescription Drug User Fee program. Policy issues relating to corproate tax reform. View registration
View all lobbying data for Ferguson Strategies Sources: Lobbyist Registration Tracker OpenSecrets.org